FDA Inspection 1109151 — Rebiscan, Inc.
The FDA completed an inspection of Rebiscan, Inc. on October 31, 2019 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 31, 2019
- Fiscal Year
- 2020
- Product Type
- Devices
- Project Area
- Radiation Control and Health Safety Act
- Location
- Boston, MA (United States)